Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will introduce pediatricians to GeneDx’s Infinity ...

Sarepta Therapeutics, a global biotechnology company engineering precision medicine solutions for rare diseases, is building a significant R&D operation in the emerging life science hub of Columbus, ...

Researchers describe minimal versatile genetic perturbation technology (mvGPT). Capable of precisely editing genes, activating gene expression and repressing genes all at the same time, the technology ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Euan Ashley's lab explores the intricate interactions of gene variants. Tiny "typos," or genetic mutations, can sneak into ...

Chroma Medicine and Nvelop Therapeutics merge to bring together best-in-class epigenetic editing technologies and next generation in vivo delivery technologies to unlock the full potential of genetic ...

In the 22nd century, manipulation of the human genome became commonplace. Techniques of genetic engineering advanced to the point where the rich could custom-build fetuses that grew into stronger, ...

Trusted as the #1 ranked genomic testing brand among pediatric and genetic providers For more than 25 years, genetics experts have relied on Infinity as the gold-standard for rare disease insights due ...